Discussion:
The genetic variants we uncover and the molecular basis for their action provide mechanistic explanations and principles for how the innate immune response to pathogens and cytokines varies across individuals. Our results also link disease-associated variants to specific immune pathways in DCs, which provides greater insight into mechanisms underlying complex human phenotypes. Extending our approach to many immune cell types and pathways will provide a global map linking human genetic variants to specifi c immunological processes. Identifying the genetic basis of variability in the host response to pathogens. A cohort of 534 individuals donated blood for (a) genotyping of common DNA variants and (b) isolation of immune DCs. DCs were stimulated with viral and bacterial components, and the variability in individuals' gene expression responses was mapped to specific DNA variants, which were then shown to affect binding of particular transcription factors. S usceptibility to complex diseases depends on both genetic predisposition and exposure to environmental factors, with interactions between the two (G × E interactions) likely contributing substantially to disease risk (1, 2) . However, the extent and mechanisms by which common human genetic variants interact with the environment remain poorly explored and have been difficult to detect in clinical studies (1, 3) . Genetic analysis of molecular traits, such as gene expression profiles, offers a promising way to dissect the molecular mechanisms underlying G × E interactions. Expression quantitative trait locus (eQTL) studies have been used to map genetic variants contributing to variation in gene expression, but have largely focused on steady-state expression in humans (4, 5) and thus have excluded G × E interactions. In model organisms, differences in growth conditions or treatment with various stimuli have revealed the existence of response eQTLs (reQTLs) (6) (7) (8) (9) , defined as QTLs associated with the change in expression after stimulation. Here, we sought to identify reQTLs in humans, to explain the mechanism by which the environment interacts with these variants, and to determine whether these variants are associated with immune-mediated diseases.
We used dendritic cells (DCs) of the innate immune system as a model system for reQTL studies, with physiological and clinical relevance. DCs play a direct role in the host recognition of pathogens using specialized sensors that engage well-characterized signaling and transcriptional networks. For example, bacterial lipopolysaccharide (LPS) activates two distinct arms of the Toll-like receptor 4 (TLR4) pathway, whereas influenza infection primarily activates the RNAsensing TLRs (for example, TLR3) and the RIG-Ilike receptors (for example, RIG-I) (10) . These, in turn, lead to the translocation of transcription factors (TFs) from the cytoplasm into the nucleus to induce the expression of immune genes, including interferon-b (IFN-b) secretion that engages the type I IFN response pathway to induce the expression of hundreds of antiviral effectors. Genetic studies have associated common variants near many genes in these pathways with risk of different inflammatory diseases (11, 12) . DCs also play a critical role in the pathologic immune responses underlying inflammatory diseases (11) (12) (13) , also reflected in recent genomewide association studies (GWAS) of several diseases (14) (15) (16) (17) , especially inflammatory bowel disease (14) .
Results

Assessing the Impact of Genetic Variation on Pathogen Sensing in Primary Human DCs
We developed an integrated experimental and computational pipeline (Fig. 1A) to identify variability in human DC responses and associate this variability with common genetic variants. First, we optimized a high-throughput protocol to isolate primary CD14 + CD16
lo monocytes from human blood samples ( fig. S1 , A to F), differentiate them into monocyte-derived DCs (MoDCs), and stimulate them with three immunostimulatory agents (Fig. 1B) : Escherichia coli LPS, influenza virus, or IFN-b (a cytokine induced by LPS and influenza). Second, we collected genomewide transcript profiles from resting and stimulated DCs from 30 healthy individuals and computationally identified a "signature" of 415 genes that would be informative of variation in the response in a larger cohort. Third, we generated 1598 transcriptional profiles [using an amplificationfree platform suitable for small cell numbers (18) ] from DCs isolated from 534 healthy individuals (295 Caucasians, 122 African Americans, and 117 East Asians) (table S1) in four states: resting, LPS-stimulated, influenza-infected, and IFN-b-stimulated. Finally, we associated expression variation with genetic variation to identify cis-and trans-eQTLs and reQTLs, and we investigated candidate reQTLs for their mechanism of action.
Variability of Pathogen-Sensing Responses Between Individuals
To assess the interindividual variability of DC responses, we first profiled genome-wide expression using microarrays in resting, LPS-stimulated, and influenza-infected MoDCs isolated from each of 30 healthy individuals (18 Caucasians, 6 Asians, and 6 African Americans). We found 1413 genes that were regulated in LPS-or influenza-treated cells [log 2 (fold change) >0.75 or <−1.5; false discovery rate (FDR) < 0.01; fig. S2A and table  S2A; see table S2 , B to I, for enriched biological processes] at 5 and 10 hours, respectively (time points selected to have maximal expression of induced clusters) ( fig. S1 , B and C).
We quantified reproducibility in these responses by recalling 12 of the 30 donors 2 to 9 months after the first collection for MoDC isolations and profiling (table S1); we identified genes whose expression interindividual variance is significantly higher than their intraindividual variance based on the serial replicates [taking into account known covariates including gender, age, and population and unknown factors using surrogate variable analysis (19) ]. Two hundred twenty-two of the 1413 regulated genes (16%) showed significantly higher (FDR < 0.1) interthan intraindividual variability, either in their absolute expression or in the differential expression (stimulated/baseline level) to at least one stimulus ( Fig. 2A and table S3 ). These results suggest that there is consistent variation in these traits that may have a genetic basis.
Expression Profiling of a Pathogen Response Signature
Mapping the genetic basis of interindividual variation in pathogen responses requires profiling of DC gene expression in a larger cohort; this poses a substantial technical challenge given the limited numbers of primary cells and multiple stimuli. Furthermore, the responses of DCs to virus, bacterial ligands, and IFN are limited in scope and do not encompass the entire genome. We therefore defined a 415-gene signature set ( Fig. 2B and table S3 ) that could be monitored in small numbers of cells using a sensitive multiplex RNA detection system (18) , allowing us to scale up our study. The signature consisted of (i) all 222 of 1413 regulated genes with greater inter-than intraindividual variability in the microarray study; (ii) all 24 regulated genes exhibiting greater inter-than intrapopulation variability (FDR < 0.1) (table S3) in the microarray study; (iii) 76 genes comprising the known components of the TLR4, TLR3, RIG-I, and IFNAR pathways (Fig. 1B) (10, (20) (21) (22) ; (iv) 61 regulated genes that play key roles in the DC response (for example, IFNB1 and IFITM3) (22) (23) (24) ; (v) 28 regulated genes residing in loci previously associated with autoimmune or infectious diseases (25) ; and (vi) 35 control genes including those that had among the lowest interindividual variance in the microarray profiles. This representative signature allowed us to monitor genes with high interindividual variability, as well as key components and responses of the pathogen-sensing pathway.
We then generated 1598 transcriptional profiles, using the 415-gene signature, from MoDCs isolated from 534 healthy individuals (and 37 serially collected replicates) in up to four conditions: resting (528 individuals), LPS-stimulated (356), influenza-infected (342), and IFN-b-stimulated (284) ( Fig. 2C; fig. S1 , E and F; and table S1). The IFN-b stimulus allowed us to partition genes that were induced by both LPS and influenza (cluster III) into those induced secondary to type I IFN signaling (cluster IIIa) or by other mechanisms shared between these bacterial and viral sensing pathways (cluster IIIb), such as nuclear factor kB (NF-kB) or activating protein 1 (AP-1) activation (Figs. 1B and 2C ). The signature expression profiles clustered similarly to those from the microarray analysis ( Fig. 2C and fig. S2C ) and captured most of the variance in the genomewide profile [cross-validation, >0.99 ground-truth Pearson correlation coefficient; fig. S2D (26) ], demonstrating the utility of the signature to capture the genome-wide response.
reQTLs That Modulate Cellular Responses to Pathogens
We mapped cis-eQTLs and cis-reQTLs by testing for association between common single-nucleotide polymorphisms (SNPs) (minor allele frequency >5%; genotyped with Illumina HumanOmniExpress BeadChip) and variation in either absolute transcript abundance (eQTL) or stimulation-induced change in transcript abundance (reQTL) in a nearby gene (in which the transcriptional start site or stop codon is within 1 Mb of the SNP). We pooled individuals from the three human populations together and included covariates and principal components to increase statistical power while avoiding systematic confounders such as population structure and expression heterogeneity. We identified 264 genes with cis-eQTLs in at least one condition (permutation FDR < 0.05) ( Fig. 3A; fig. S3 , A to C; and table S4, A to D) (27). Notably, 22 of 264 genes also associated with additional independent cis-eQTLs after conditioning on the top five most significant SNPs in each cis-eQTL region (table S6 and fig. S3D ) (27), which reflects the complexity of the regulatory landscape around each gene.
We detected 121 cis-reQTLs ( only in the influenza condition (for example, IFNA21; Fig. 3C and fig. S3B ; meta-analysis, P < 1 × 10
; permutation FDR = 0.02 to 0.03); 15 in both the LPS and influenza conditions (for example, TEC; Fig. 3C and fig. S3B ); and 57 in all three stimulation conditions (for example, ARL5B, SLFN5, and CLEC4F; Fig. 3 , C to E, and fig. S3B ), likely reflecting activation of the shared IFN-b pathway. We hypothesized that causal variants driving cis-reQTLs alter the sequence of genomic elements that respond to TFs downstream of the pathogen-sensing receptors (Fig. 3F) , and represent gene-by-environment interactions.
To validate cis-reQTLs, we quantified allelespecific expression for pan-stimulation-specific associations in heterozygote individuals (Fig. 3,  D inter-versus intraindividual variability; 61 (14%) are curated, regulated genes with a known function in the innate immune response; 76 (17%) are curated regulators in the TLR4, TLR3, RIG-I, and IFNAR pathways; 41 (9%) are control genes including low-variance genes, sex-specific genes, and nonexpressed genes; 28 (6%) are regulated genes that were reported in the regions of autoimmune and infectious disease GWAS; and 21 (5%) are regulated genes that showed significant inter-versus intrapopulation variability. (C) Gene expression heat map of the 415-gene signature in MoDCs from the microarray study (30 individuals) and the Nanostring study (534 individuals). Each row represents a gene; each column represents a donor sample at baseline, stimulated with LPS, infected with FLU, or stimulated with IFN-b. Rows were clustered by k-means clustering of Nanostring data set with major clusters (I, II, IIIa, IIIb, and IV) labeled. Between the two heat maps, each row was labeled with colored dashes corresponding to one of the six categories described in (B). disequilibrium with the most significant reQTL SNP (rs11867191, R 2 = 0.501 CEPH, CEU). As predicted, transcripts derived from the major and minor alleles differed in expression after stimulation with LPS (SLFN5: P < 0.001, t test; CLEC4F: P < 0.01); influenza (SLFN5: P < 0.001; CLEC4F: P < 0.01); or IFN-b (SLFN5: P < 0.001; CLEC4F: P < 0.001) but not at baseline (Fig. 3, D and E) .
Cis-reQTLs That Alter the Sequence of TF Binding Sites
We hypothesized that the causal variants underlying cis-reQTLs functionally alter the chromosomal binding sites of TFs activated by one or more stimuli. To fine map reQTLs, we performed a trans-ethnic meta-analysis (28) of imputed variants in each population (~10 M). We then examined whether the most highly associated meta-reQTLs overlap with TF binding sites identified in highthroughput human chromatin immunoprecipitation with massively parallel DNA sequencing (ChIP-seq) data sets (for example, ENCODE) or computationally predicted conserved regulatory elements (29-31). We found substantial enrichment (table S7) Among the 57 genes (for example, SLFN5, CLEC4F, and ARL5B; Fig. 3F ) with cis-reQTLs in all three stimuli, we observed that the most significant cis-reQTL in the (i) SLFN5 locus (rs11080327) lies in an ENCODE ChIP-seq signal (29) for STAT1 (Fig. 4 , A to C); (ii) CLEC4F locus (rs35856355) alters a commonly occurring cytosine in a canonical IFN-stimulated response element (ISRE) that is a target of IFN-activated TFs (Fig. 4 , B and C) (22, (30) (31) (32) ; and (iii) ARL5B locus (rs2130531) changes a guanine in the canonical ISRE motif (Fig. 4, B and C) . Additional cis-reQTLs that alter putative STAT binding sites based on ChIP-seq data or predicted ISRE motifs include rs10086852 (PTK2B), rs1981760 (NOD2), rs73023464 (C19ORF12), rs1331717 (IFI44), and rs12064196 (IFI44) (Fig.  4A) . Because STAT TFs are activated downstream of the type I IFN receptor (IFNAR) and bind to ISRE motifs (Fig. 4A) (22) , we hypothesized that the SNPs in these sites are likely causal SNPs within their respective cis-reQTL regions.
Cis-reQTLs That Affect Differential Binding of Stimulus-Activated TFs
To experimentally validate our predicted regulatory mechanisms, we determined whether IFN-bactivated TFs bind differentially at these SNPs. Using radiolabeled 24-to 26-bp (base pair) doublestranded DNA (dsDNA) probes in electrophoretic mobility shift assays (EMSAs), we found that probes encompassing the major alleles (rs35856355 C and rs2130531 G , which are associated with increased expression in CLEC4F and ARL5B), but not the minor alleles, shifted after incubation with IFN-b-stimulated MoDC nuclear lysates (Fig. 4D) . Consistently, nonradiolabeled major, but not minor, allele probes competed for binding to the IFN-b-stimulated nuclear factors ( fig. S4A ). By incubating with antibodies to TFs known to bind the ISRE element, we found that IRF1 (IFN-regulatory factor 1) supershifted the low-molecular weight band and STAT2 and IRF9 supershifted the higher-molecular weight band, consistent with the known complex of these latter two proteins (32) (Fig. 4D) . These results suggested that the SNPs in CLEC4F and ARL5B alter the binding of IFN-activated IRF1, STAT2, and IRF9 TFs.
To directly test the functional effects of the SNPs, we cloned 150-to 200-bp genomic regions surrounding rs11080327 (SLFN5), rs35856355 (CLEC4F), and rs2130531 (ARL5B) upstream of a luciferase reporter driven by a minimal promoter (Fig. 4E) . For each region, we created two constructs that differ only at the respective SNPs. Because almost all cell types respond to IFN-b stimulation, we transfected the reporter constructs into human embryonic kidney 293 (HEK293) cells and stimulated the cells with IFN-b. Consistent with our hypothesis, the constructs containing the major alleles of rs11080327 (SLFN5), rs35856355 (CLEC4F), and rs2130531 (ARL5B) induced 11.6-, 2.1-, and 1.5-fold, respectively, more luciferase production than the cognate constructs containing the minor alleles (t test, P < 0.001, P < 0.001, and P < 0.01, respectively) (Fig.  4E) . Furthermore, mutation of motif-conserving nucleotides across the CLEC4F ISRE motif reduced induction by IFN-b, whereas mutation of nonconserved nucleotides did not ( fig. S4B) , consistent with the ISRE consensus motif.
Finally, to further test (33) the functionality of rs11080327-the SLFN5 variant with the strongest functional effect-in its native chromosome, we directly edited the genome using the CRISPR system (34, 35) , converting the heterozygous rs11080327
A/G in HEK293 cells to a homozygous rs11080327 G/G (Fig. 4F and fig. S4C ). We then stimulated both native and CRISPRconverted cells with IFN-b. The fold induction of SLFN5 decreased from 3.64 in heterozygous cells to 1.03 in the converted rs11080327 (G) homozygotes, whereas the induction of other genes was unaffected (Fig. 4F and fig. S4C , independent CRISPR construct).
The enrichment, EMSA, reporter assays, and directed mutagenesis results suggest that we have identified causal variants in some of these cisreQTL regions and demonstrate that the reQTLs occur because of differential binding of stimulusactivated TFs.
A Trans-eQTL That Also Associates with IRF7 as a Cis-eQTL We next attempted to detect cases where variation in gene expression is explained by distant genetic variants acting in trans. We noted that ciseQTLs for regulator genes tend to have smaller effect sizes and less significant P values than those for regulated genes ( fig. S3E ). To decrease the multiple testing burden of detecting transassociations, we restricted testing SNPs local to genes on our gene signature set. A number of these are cis-eQTLs associated with the expression of genes encoding regulators (for example, TFs) in pathways that we stimulated (Fig. 5A ). Of these, rs12805435 was the most significant, associating with the expression of the master antiviral TF IRF7 in cis only after influenza, LPS, or IFN-b stimulation (table S4, A to D). This SNP associated with both the expression and induction of seven additional genes in trans (that is, the transcriptional start site or stop codon is located >1 Mb from the SNP) only after influenza infection: NMI, IFNA4, IFNA10, IFNA13, IFNA21, IFNA17, and IFNA5 (P < 6.26 × 10
in expression, P < 1.68 × 10 −5 in differential expression) (Fig. 5B and tables S8 to 10).
To test whether the trans-associated genes are indeed targets of IRF7, we infected MoDCs that overexpressed IRF7 or a control gene with influenza virus, and found that IRF7 overexpression induced the expression of IFNA2, IFNA13, and IFNA14 in influenza-infected cells (Fig. 5C ). In addition, in HEK293 cells, which normally express very low levels of IRF7, we overexpressed IRF7 and observed induction of NMI, IFNA4, IFNA10, IFNA13, IFNA14, and IFNA21 (Fig.  5D ), suggesting that IRF7 is sufficient to drive downstream expression. We have thus identified a stimulus-specific cis-eQTL associated with IRF7 expression, which is also a trans-reQTL that underlies the variability of IFN induction in response to influenza infection in humans.
DC reQTLs That Overlap with Autoimmune and Infectious Disease SNPs from GWAS
We examined the subset of loci associated in GWAS with inflammatory disorders. We first extended an analysis of Crohn's disease in which loci are enriched for genes specifically expressed in DCs (12, 14) to multiple sclerosis, celiac disease, psoriasis, and leprosy ( fig. S5A) . We found that genes nearest to the susceptibility loci for these diseases were enriched not only in DCspecific genes but also in genes induced by LPS and/or influenza ( fig. S5B) , which suggests that some of the GWAS loci modulate the expression of the corresponding genes in activated DCs.
Supporting this hypothesis, 15 cis-reQTLs and 23 cis-eQTLs that were not significant at baseline but only became significant after stimulation are the same SNPs previously identified in GWAS of autoimmune and infectious diseases, including Crohn's disease, multiple sclerosis, celiac disease, psoriasis, and leprosy (25) (Fig. 6,  A and B, and table S11 ). These include NOD2 with leprosy (rs9302752), IRF7 with systemic lupus erythematosus (SLE) (rs4963128), TRAF1 with rheumatoid arthritis (rs881375), and CREM with Crohn's disease (rs12242110) and ulcerative colitis (rs4246905). For example, rs9302752-a SNP previously associated with susceptibility to leprosy (17)-was associated in our study with the absolute and fold expression of NOD2 under IFN-b stimulation (P = 3.49 × 10 ); yellow circles represent stimulus-specific cis-eQTLs (P < 10
−7
).
www.sciencemag.org SCIENCE VOL 343 7 MARCH 2014 immunity (36) . Similarly, rs4963128-a variant associated with SLE (37)-was associated in our study with the expression of IRF7 after IFN-b stimulation (P = 1.10 × 10 −16 ) but not at baseline (Fig. 6A ), in line with the importance of type I IFN responses in SLE pathogenesis (38) . We note that rs4963128 is on the same haplotype (R 2 = 0.69, D′ = 0.94) as the IRF7 SNP rs12805435 that is associated with the trans-reQTL effect described above. These results suggest a role for innate immune pathogen-sensing pathways in the pathogenesis of these inflammatory disorders.
Discussion
Although genetic association studies have identified alleles that confer disease risk, little is known about how these genetic variants contribute to disease through their effects on specific biological processes and their interaction with environmental stimuli. We addressed this question by quantifying the DC response to pathogens in a set of genotyped individuals, and then leveraged our understanding of these pathways to explain the mechanisms underlying the observed genotype-environment-phenotype interactions.
Many of the QTL associations we identified are only detectable in the presence of specific stimuli, which underscores the need to activate cells to capture additional genotype-phenotype relations (39) (40) (41) . Furthermore, few eQTL studies have definitively identified the causal variants underlying the associations. By measuring variability in hundreds of individuals, applying stimuli that partially overlap in their downstream pathways, and leveraging genomic data sets such as the 1000 Genomes Project and ENCODE (29, 42), we (i) pinpointed causal variants in reQTL regions and (ii) identified the stimulusactivated TFs that bind differentially at these SNPs, which explain some of the G × E interactions. Our data set can thus be used to explore mechanisms of G × E interactions (43) and are consistent with deoxyribonuclease I sensitivity QTL (44) and ChIP-seq QTL (45) studies that showed that differential TF binding between individuals is pervasive in resting cells.
The reQTLs we identified provide genetic explanations for interindividual variation in innate immune responses. This is best exemplified by the trans-reQTL in the IRF7 locus that regulates the type I IFN antiviral response. Our study reveals the effects of this trans-reQTL on target genes (antiviral IFN module) in the context of a particular cell type (DCs) and in response to specific ligands (influenza). The changes in this immune response are, in turn, likely to affect organismal phenotypes that are driven by the IFN module, including susceptibility to viral infections and autoimmune diseases like SLE.
Overall, our high-throughput experimental pipeline and integrative analysis of primary human DCs reveals abundant gene-by-environment interactions, points to the effects of disease variants on pathogen detection, and motivates extending our approach to a wide variety of immune cell types and stimulatory conditions to better explain the impact of human genetic variation on the immune response.
